Dazostinag sodium is under clinical development by Takeda Pharmaceutical and currently in Phase II for Oral Cavity (Mouth) Cancer.

Nivolumab is under clinical development by Bristol-Myers Squibb and currently in Phase II for Oral Cavity (Mouth) Cancer.

A new review of 19 international studies compared bowel cancer rates for women who had taken an oral contraceptive between the mid-1960s and 1980s. They found that as more women took the Pill and ...

A second cancer treatment has so far proved 100 per ... include: 572016 - A daily oral pill to tackle breast, bladder, lung, gastric, head and neck cancers. Cervarix - A vaccine, to be tested ...

Medicare provides essential coverage for cancer treatment, but the specifics of coverage, costs, and eligibility vary ...

Prostate cancer is the most common ... becoming the first and only oral GnRH receptor antagonist on the market. Current injectable drugs in the class include leuprorelin, triptorelin, goserelin ...